Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery under general anesthesia
ChiCTR2200059115Phase 4Not yet recruiting
- Sponsor
- Taizhou Hospital of Zhejiang Province
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Olanzapine arm with Placebo arm (2 arms). Primary endpoint: Frequency and severity of postoperative nausea and vomiting. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
olanzapine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2200059115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059115.